CTX131 Trademark
CTX131 is a USPTO trademark filed by CRISPR Therapeutics AG. Status: Abandoned.
Trademark Facts
| Mark | CTX131 |
|---|---|
| Serial Number | 97371566 |
| Status | Abandoned |
| Filing Date | 2022-04-20 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals), 042 (Software & IT) |
| Owner | CRISPR Therapeutics AG |
| Attorney of Record | Tiffany D. Gehrke |
| Prosecution Events | 44 |
| Latest Event | MAB2 on 2026-01-15 |
Goods & Services
Cells for medical or clinical use in the field of CAR T cell therapy for the treatment of hematologic malignancies; pharmaceutical and biopharmaceutical agents for the treatment of cancer in the field of CAR T cell therapy; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of cancer in the field of CAR T cell therapy; Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders in the field of CAR T cell therapy for the treatment of hematologic malignancies; gene editing, namely, pharmaceutical research and development in the field of CAR T cell therapy for the treatment of hematologic malignancies